🇺🇸 FDA
Patent

US 11667903

Tracking and manipulating cellular RNA via nuclear delivery of CRISPR/CAS9

granted A61KA61K38/465A61K48/0058

Quick answer

US patent 11667903 (Tracking and manipulating cellular RNA via nuclear delivery of CRISPR/CAS9) held by The Regents of the University of California expires Mon Jun 01 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Jun 06 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 01 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K38/465, A61K48/0058, A61P, A61P21/00